Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older (any gender)
- People diagnosed with aggressive non-Hodgkin's lymphoma or multiple myeloma who are planned to receive, or have started no more than two cycles of, chemotherapy — or people with myeloma or lymphoma who need more intensive treatment supported by a stem cell transplant using their own cells
- People who are reachable by phone during the study period
- People who are able to return home after their initial hospital stay
- People who are covered by French social security
- People who are able to read and speak French
- People who have signed a consent form agreeing to take part freely and with full information
Who may not be able to join:
- People whose life expectancy is estimated to be less than 3 months
- People with moderate to severe cognitive (thinking or memory) difficulties, as measured by a standard assessment test (confirm with trial site)
- People with a psychiatric condition or physical disability that would prevent them from using the study device (confirm with trial site)
- People who have a pacemaker
- People who are already taking part in another interventional research study
- People who are pregnant
- People who are currently detained or deprived of their liberty
- People who are under a legal protection order, such as guardianship or curatorship
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01.58.41.42.90
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients who agreed to participate in research
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.